These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33830730)

  • 1. Virus-Mimicking Mesoporous Silica Nanoparticles with an Electrically Neutral and Hydrophilic Surface to Improve the Oral Absorption of Insulin by Breaking Through Dual Barriers of the Mucus Layer and the Intestinal Epithelium.
    Zhang Y; Xiong M; Ni X; Wang J; Rong H; Su Y; Yu S; Mohammad IS; Leung SSY; Hu H
    ACS Appl Mater Interfaces; 2021 Apr; 13(15):18077-18088. PubMed ID: 33830730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics.
    Guo S; Liang Y; Liu L; Yin M; Wang A; Sun K; Li Y; Shi Y
    J Nanobiotechnology; 2021 Jan; 19(1):32. PubMed ID: 33499885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen Delivery.
    Tu J; Du G; Reza Nejadnik M; Mönkäre J; van der Maaden K; Bomans PHH; Sommerdijk NAJM; Slütter B; Jiskoot W; Bouwstra JA; Kros A
    Pharm Res; 2017 Aug; 34(8):1693-1706. PubMed ID: 28536970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming Barriers Associated with Oral Delivery of Differently Sized Fluorescent Core-Shell Silica Nanoparticles.
    Erstling JA; Bag N; Gardinier TC; Kohle FFE; DomNwachukwu N; Butler SD; Kao T; Ma K; Turker MZ; Feuer GB; Lee R; Naguib N; Tallman JF; Malarkey HF; Tsaur L; Moore WL; Chapman DV; Aubert T; Mehta S; Cerione RA; Weiss RS; Baird BA; Wiesner UB
    Adv Mater; 2024 Jan; 36(1):e2305937. PubMed ID: 37689973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication of mesoporous silica nanoparticles for releasable delivery of licorice polysaccharide at the acne site in topical application.
    Ain NU; Khan B; Zhu K; Ji W; Tian H; Yu X; Yi L; Li D; Zhang Z
    Carbohydr Polym; 2024 Sep; 339():122250. PubMed ID: 38823917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantioselective Oral Absorption of Molecular Chiral Mesoporous Silica Nanoparticles.
    Wang Y; Zhao L; Dai Y; Xu M; Zhou R; Zhou B; Gou K; Zeng R; Xu L; Li H
    Adv Mater; 2023 Dec; 35(49):e2307900. PubMed ID: 37839052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable Multicomponent Biomimetic Gel Composed of Inter-Crosslinked Dendrimeric and Mesoporous Silica Nanoparticles Exhibits Highly Tunable Elasticity and Dual Drug Release Capacity.
    Wang J; Li B; Pu X; Wang X; Cooper RC; Gui Q; Yang H
    ACS Appl Mater Interfaces; 2020 Mar; 12(9):10202-10210. PubMed ID: 32023033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of L-tartaric Acid Modified Chiral Mesoporous Silica Nanoparticle as a Drug Carrier: Structure, Wettability, Degradation, Bio-Adhesion and Biocompatibility.
    Hu B; Wang J; Li J; Li S; Li H
    Int J Nanomedicine; 2020; 15():601-618. PubMed ID: 32099354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Monoacylglycerol Mimetic Liposomes to Promote Intestinal Lymphatic Transport for Improving Oral Bioavailability of Dihydroartemisinin.
    Zheng B; Pan F; Shi M; He C; He B; Wang R; Ren G; Yang S; Zhang S
    Int J Nanomedicine; 2024; 19():5273-5295. PubMed ID: 38859952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral In-Situ Nanoplatform with Balanced Hydrophobic-Hydrophilic Property for Transport Across Gastrointestinal Mucosa.
    Attar ES; Jayakumar S; Devarajan PV
    AAPS PharmSciTech; 2024 May; 25(5):113. PubMed ID: 38750336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Study on Folate-Targeted Mesoporous Silica Nanoparticles Loaded with 5-Fluorouracil for the Enhanced Treatment of Gynecological Cancers.
    Almomen A; Alhowyan A
    J Funct Biomater; 2024 Mar; 15(3):. PubMed ID: 38535267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of virus-capsid mimicking biologic-shell based versus polymeric-shell nanoparticles for enhanced oral insulin delivery.
    Cui Z; Cui S; Qin L; An Y; Zhang X; Guan J; Wong TW; Mao S
    Asian J Pharm Sci; 2023 Sep; 18(5):100848. PubMed ID: 37881796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multichiral Mesoporous Silica Screws with Chiral Differential Mucus Penetration and Mucosal Adhesion for Oral Drug Delivery.
    Wang Y; Li W; He Z; Yin W; Chen X; Zhang J; Li H
    ACS Nano; 2024 Jun; 18(25):16166-16183. PubMed ID: 38867485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability.
    Lamson NG; Berger A; Fein KC; Whitehead KA
    Nat Biomed Eng; 2020 Jan; 4(1):84-96. PubMed ID: 31686002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Milk exosomes anchored with hydrophilic and zwitterionic motifs enhance mucus permeability for applications in oral gene delivery.
    Zhang C; Zhang H; Millán Cotto HA; Boyer TL; Warren MR; Wang CM; Luchan J; Dhal PK; Carrier RL; Bajpayee AG
    Biomater Sci; 2024 Jan; 12(3):634-649. PubMed ID: 38047368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-Bionic Mesoporous Silica Nanoplatform for Malignant Tumor Inhibition via Effective Cellular Uptake and Precise Drug Delivery.
    Yang X; Xie Y; Liao X; Zheng T
    ChemMedChem; 2023 Nov; 18(22):e202300439. PubMed ID: 37755120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Delivery of Peptide Nucleic Acid by Biomimetic Nanoparticles Based on Extracellular Vesicle-coated Mesoporous Silica Nanoparticles.
    Chen W; Lai Q; Zhang Y; Mo L; Liu Z
    Curr Med Chem; 2024 Jan; ():. PubMed ID: 38251696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Characterization of Mesoporous Silica (Un)loading by Gemcitabine and Ibuprofen - An Interplay of Salt-Bridges and Hydrogen Bonds.
    Aziz A; Macht M; Becit B; Zahn D
    J Pharm Sci; 2024 Mar; 113(3):785-790. PubMed ID: 38070777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: Application to bevacizumab.
    Pangua C; Espuelas S; Martínez-Ohárriz MC; Vizmanos JL; Irache JM
    Drug Deliv Transl Res; 2024 May; 14(5):1189-1205. PubMed ID: 37880504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface functionalization affects the retention and bio-distribution of orally administered mesoporous silica nanoparticles in a colitis mouse model.
    Schmid R; Volcic M; Fischer S; Qu Z; Barth H; Popat A; Kirchhoff F; Lindén M
    Sci Rep; 2023 Nov; 13(1):20175. PubMed ID: 37978264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.